Dalbavancin (Compound)

Synonyms:Dalbavancin, dalbavancin B0, BI397, VER001, A-A-1, UNII-B0U42518WL, CHEBI:82721, B0U42518WL, BI 397, MDL 64,397, 171500-79-1, VER 001, VER-001, BI-397, MDL 63,397, UNII-808UI9MS5K, VERO001, Dalbavancin [USAN:INN:BAN], 808UI9MS5K, CHEMBL3301669, HY-17586A, MDL-64397, NCGC00420878-02, CS-0113796, Q5210237, UNII-808UI9MS5K component KGPGQDLTDHGEGT-SZUNQUCBSA-N, Ristomycin A aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-(2-deoxy-2-((10-methyl-1-oxoundecyl)amino)-beta-D-glucopyranuronosyl)-38-(((3-(dimethylamino)propyl)amino)carbonyl)-42-O-alpha-D-mannopyranosyl-N(sup 15)-methyl-, Ristomycin A aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-(2-deoxy-2-((10-methyl-1-oxoundecyl)amino)-beta-D-glucopyranuronosyl)-38-(((3-(dimethylamino)propyl)amino)carbonyl)-42-O-alpha-D-mannopyranosyl-N15-methyl-
Pubchem:PUBCHEM:16134627
Id:5485c5ad-499e-5cec-b2b1-f5dfc6e37957
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Dalbavancin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Dalbavancin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Dalbavancin.

Results found

Linked to

 

Label

Description

 

Collection

DrugPage Collection: (DrugCentralID:00777; PubChem_CID:16134627, FILE=drugcentral_drug_00777.json)

Knowledge Graph Assertion

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.